[ad_1]
DUBLIN – (BUSINESS WIRE) – July 12, 2018 – The report "2018 Dyspepsia Drug Development – Pipeline Analysis Report" was added to the ResearchAndMarkets.com offer
to help researchers and organizations Finance and Regulatory, the publisher has developed a comprehensive report on the Dyspepsia pipeline. The report provides information on different therapeutic candidates in preclinical, research, discovery, NDA / IND, pre-registration, phase 1, phase 2 and phase 3 trials). Drugs in development directly and in combination with other drugs are also included.
kAmrFCC6? E DE2EFD [56G6=@A>6?E2=A92D6[A2CE:4:A2E:?84@>A2?:6D2?56?E:E:6D[C646?E56G6=@A>6?ED[@CA92?5CF8^72DEEC24<^ @E96C 56D:8?2E:@?D[ 5CF8 4=2DD 2C6 AC@G:565 7@C 6249 sJDA6AD:2 A:A6=:?6 AC@5F4E] |6492?:D> @ 7 p4E: @? 2? 5 E96 E2C86E 2C62 @ 7 E96 A: A6 =:? 6 AC @ 5F4E 2C6 2 = D @ AC @ G: 565] uFCE96C [ 4=:?:42= 2?5 AC64=:?:42= EC:2=D 2=@?8 H:E9 C6DF=ED @7 E96 EC:2=D 2C6 2=D@ :?4=F565 😕 E96 C6A@CE] k ^ Am
kAmx? 255: E: @? E @ 4 @> A = 6E6 56E2: = D @ 7 6249 AC @ 5F4E [E96C6A@CEAC@G:56D<6J EC6?5D :? sJDA6AD:2 A:A6=:?6 DEF5:6D] %96 AC@5F4ED F?56C 56G6=@A> 6? E 2C6 42E68 @ C: K65 244 @ C5:? E @ E96: C 56G6 = @ A> 6? E A92D6 [ >6492?:D> 2?5 4@>A2?J E@ AC@G:56 56E2:=65 :?D:89ED :?E@ E96 EJA6 @7 5CF8D 36:?8 56G6=@A65 2?5 E96 DE286D @7 56G6=@A>6?E] k ^ Am
kAmz6J% @ A: 4D r @ G6C65ik ^ Am
kAm` sJDA6AD: 2 !: A6 =:? 6 p? 2 = JD: Dk ^ Am
kAma sJDA6AD: 2 r @> A2? J (: D6 !: A6 =:? 6 p? 2 = JD: Dk ^ Am
kAmb sJDA6AD: 2 # U2> Ajs !: A6 =:? $ 6? 2AD9 @ EDk ^ Am
kAmc # 646? E s6G6 = @ A> 6? ED 😕 sJDA6AD: 2 !: A6 =:? 6k ^ Am
kAmd pAA6? 5: Ik ^ Am
kAmr @> A2 ?: 6D u62EFC65k ^ Am
kAmp3: 56% 96C2A6FE: 4Ds26H @@? 8! 92C> 246FE: 42 = r @ {E5s @? 8 p $% r @] [ {E5] x = s @? 8! 92C> 246FE: 42 = r @ {E5 {%% q: @ ! ## EQU2 ## U2> Aj% 649 + 6C: 2! 92C> 246FE: 42 = r @ {E5k ^ Am
kAmu @ C> @ C6 😕 7 @ C> 2E: @? 23 @ FE E9: D C6A @ CE G: D: E2 E2C86E1QU> 52D9j3 = 2? 2C <6ED]4@> ^ C6D62C49 ^? GI77h? 5JDA6AD: 2TtaTg_Thc5CF8nHlcQm9EEADi ^^ HHH] C6D62C492? 5> 2C <6ED]4@> ^ C6D62C49 ^? GI77h ^ 5JDA6AD: 2-5CF8nHlck ^ 2mk ^ Am
kAm :: 6H D @ FC46 G6CD: @? @? 9C67lQ9EEAi ^^ 3FD 😕 6DDH: C6] 4 @> Qm3FD:? 6DDH: C6] 4 @> k ^ 2mik2 E2C86E1QU> 52D9j3 = 2? ^? 6HD ^ 9 @> 6 ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ ^ Qm9EEADi ^^ HHH] 3FD:? 6DDH: C6] 4 @> ^? 6HD ^ 9 @> 6 ^ a_`g_f`a__dce` ^ 6? ^ K ^ 2mk ^ Am
kAmr ~}% pr% i 9C67lQ9EEAi ^^ # 6D62C49p? 5 | 2C <6ED]4@> Qm # 6D62C49p? 5 | 2C <6ED]4@> k ^ 2mk ^ Am
kAm {2FC2 (@@ 5 [$ 6 ?: @ C | 2? 286Ck ^ Am
kAmk2 9C67lQ> 2: = E @ iAC6DDoC6D62C492? 5> 2C <6ED]4@> QmAC6DDoC6D62C492? 5> 2C <6ED]4@> k ^ 2mk ^ Am
kAmu @ C t] $]% ~ 77: 46 w @ FCD r2 == ` h`f b __ _ cf_k ^ Am
kAmu @ C &] $] ^ rp}% @ == uC66 r2 == g __ dae geb_k ^ Am
kAmu @ C v |% ~ 77: 46 w @ FCD r2 == Zbdb ` c`e gh__k ^ Am
kAm # 6 = 2E65% @ A: 4DisCF8 s: D4 @ G6CJ [v2DEC @ 😕 E6DE 😕 2 = sCF8Dk ^ Am
kAmzt * (~ # sik ^ Am
kAmx} s & $% # * zt * (~ # if wtp {% wr {x} xrp {% # xp {$! Wp # | prt &% xrp {k ^ Am
kAm $ ~ & # rti # 6D62C49 2? 5 | 2C <6EDk ^ Am
kAmr @ AJC: 89E qFD 😕 6DD (: C6 a_`g] k ^ Am
kAm! & Qi _f ^ `a ^ a_`g _hi_b p | ^ sx $ ri _f ^ `a ^ a_`g _hi_b p | k ^ Am
kAmk2 9C67lQ9EEAi ^^ HHH] 3FD 😕 6DDH: C6] 4 @> ^? 6HD ^ 9 @> 6 ^ a_`g_f`a__dce` ^ 6? Qm9EEAi ^^ HHH] 3FD 😕 6DDH: C6] 4 @> ^? 6HD ^ 9 @> 6 ^ a_`g_f`a__dce` ^ 6? K ^ 2mk ^ Am
Source link
